MeiraGTx Holdings (MGTX) Return on Capital Employed (2018 - 2025)
MeiraGTx Holdings (MGTX) reported Return on Capital Employed of 112.26% for Q4 2025, down 3890.0% on a YoY basis from 2.96% in Q4 2024, and up 71.81% quarter-over-quarter from 398.16% in Q3 2025.
MeiraGTx Holdings (MGTX) Return on Capital Employed (2018 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Return on Capital Employed for 8 years, with the latest figure at 112.26% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed fell 3890.0% year-over-year to 112.26%; the trailing twelve-month figure through Dec 2025 stood at 112.26% (down 3890.0% YoY), and the FY2025 full-year result was 78.77%, down 961.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 112.26%, up from 398.16% in the prior quarter.
- The five-year high for Return on Capital Employed was 23.11% in Q1 2021, with the low at 398.16% in Q3 2025.
- Historically, Return on Capital Employed has averaged 73.57% across 5 years, with a median of 55.47% in 2023.
- Annual changes were most pronounced in 2021 — Return on Capital Employed slumped 43 bps — and 2025, when it plunged 31926 bps.
- MeiraGTx Holdings' Return on Capital Employed stood at 29.86% in 2021, then slumped by 71 bps to 51.09% in 2022, then declined by 17 bps to 59.62% in 2023, then slipped by 23 bps to 73.36% in 2024, then tumbled by 53 bps to 112.26% in 2025.
- The last three Return on Capital Employed figures came in at 112.26% (Q4 2025), 398.16% (Q3 2025), and 99.99% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | -112.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -112.26% |
| Sep 30, 2025 | -398.16% |
| Jun 30, 2025 | -99.99% |
| Mar 31, 2025 | -81.76% |
| Dec 31, 2024 | -73.36% |
| Sep 30, 2024 | -78.91% |
| Jun 30, 2024 | -70.22% |
| Mar 31, 2024 | -56.23% |
| Dec 31, 2023 | -59.62% |
| Sep 30, 2023 | -59.66% |
| Jun 30, 2023 | -54.71% |
| Mar 31, 2023 | -53.75% |
| Dec 31, 2022 | -51.09% |
| Sep 30, 2022 | -40.57% |
| Jun 30, 2022 | -40.84% |
| Mar 31, 2022 | -33.33% |
| Dec 31, 2021 | -29.86% |
| Sep 30, 2021 | -30.65% |
| Jun 30, 2021 | -23.25% |
| Mar 31, 2021 | -23.11% |